GAO chides CMS over delayed nursing home reporting, antipsychotic transparency
By
Kimberly Marselas
Jun 23, 2023
Some Care Compare information on nursing homes is too old and some is too hard to understand, reported a government watchdog.
‘Unfair’ posting of disputed citations will tarnish operators: experts
By
Kimberly Marselas
Jan 19, 2023
The decision to post disputed nursing home citations on a government website for consumers riled providers and legal experts Wednesday.
Need a fresh survey strategy? CMS lays out 3
By
Kimberly Marselas
Dec 05, 2023
CMS officials have delivered an early gift to help providers like you map out where they should focus their compliance efforts — not just for 2024, but for 2025 as well.
With scope unknown, nursing homes brace for new schizophrenia audits
By
Kimberly Marselas
Feb 10, 2023
Three weeks after federal officials announced they would begin auditing nursing homes for overuse of schizophrenia diagnoses, providers are still looking for answers about what those investigations will...
Audits trigger new concern over aging CMS antipsychotic standards
By
Kimberly Marselas
May 03, 2023
Worries over federal audits designed to monitor nursing homes for inappropriate schizophrenia diagnosing continued to mount as some providers learned they had “failed” their check-ups months into the...
Providers call for broader antipsychotic exclusions to help reduce schizophrenia diagnoses
By
Kimberly Marselas
Mar 31, 2023
Providers and quality experts are questioning why the agency hasn’t done more to review its quality measure for antipsychotic drug use.
With ‘hundreds’ of facilities audited over schizophrenia, CMS pursues harsher antipsychotics stance
By
Kimberly Marselas
Jan 19, 2024
With half of nursing homes audited in a new process admitting to misdiagnosing schizophrenia patients, the Centers for Medicare & Medicaid Services is extending its drive to reduce the use of certain drugs...
As antipsychotic use appears to backslide among nursing home residents, risks mount
By
Kimberly Marselas
Oct 11, 2021
For more than a decade, patient advocates and federal regulators have called for a reduction in nursing homes’ use of antipsychotic medications, a class of drugs once widely associated with controlling...
CMS leader balks on broader use of antipsychotic drugs
By
Kimberly Marselas
Apr 25, 2023
One of the nation’s top nursing home regulators is opposed to broadening exclusions for the use of antipsychotic medications, he told attendees of a national conference Friday.